In: ACS Omega, 2020, vol. 5, no. 38, p. 24724–24732
Cellular delivery of DNA vectors for the expression of therapeutic proteins is a promising approach to treat monogenic disorders or cancer. Significant efforts in a preclinical and clinical setting have been made to develop potent nonviral gene delivery systems based on lipoplexes composed of permanently cationic lipids. However, transfection efficiency and tolerability of such systems are in...
|
In: Journal of Inherited Metabolic Disease, 2009, vol. 32, no. 1, p. 1-2
|
In: Journal of Inherited Metabolic Disease, 2011, vol. 34, no. 3, p. 843-843
|
In: Journal of Inherited Metabolic Disease, 2011, vol. 34, no. 3, p. 819-826
|
In: Journal of Inherited Metabolic Disease, 2010, vol. 33, no. 6, p. 677-680
|
In: European Journal of Pediatrics, 2005, vol. 164, no. 6, p. 395-396
|
In: Pteridines, 1996, vol. 7, no. 3, p. 91-93
|
In: Pteridines, 1993, vol. 4, no. 1, p. 1-10
|
In: Brain, 2015, vol. 138, no. 10, p. 2948-2963
|
In: Pteridines, 1995, vol. 6, no. 3, p. 123-125
|